TS-1：大腸癌治療薬市場分析...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 11
3 Disease Overview 12
3.1 Etiology and Pathophysiology 12
3.1.1 Etiology 12
3.1.2 Pathophysiology 14
3.2 Clinical Staging 15
3.3 Symptoms 16
4 Disease Management 18
4.1 Diagnosis and Treatment Overview 18
4.1.1 Screening and Diagnosis 18
4.1.2 Treatment Guidelines and Leading Prescribed Drugs 21
4.1.3 Clinical Practice 25
5 Competitive Assessment 32
5.1 Overview 32
6 TS-1 (Tegafur, Gimeracil, Oteracil) 34
6.1 Overview 34
6.2 Efficacy 35
6.3 Safety 35
6.4 SWOT Analysis 36
6.5 Forecast 36
7 Appendix 38
7.1 Bibliography 38
7.2 Abbreviations 43
7.3 Methodology 46
7.4 Forecasting Methodology 46
7.4.1 Diagnosed Colorectal Cancer Patients 46
7.4.2 Percent Drug-Treated Patients 47
7.4.3 General Pricing Assumptions 47
7.4.4 Average Body Weight and Surface Area Across the 8MM 48
7.4.5 Individual Drug Assumptions 49
7.4.6 Generic Erosion 49
7.5 Primary Research – KOLs Interviewed for this Report 50
7.6 Primary Research – Prescriber Survey 52
7.7 About the Authors 53
7.7.1 Analyst 53
7.7.2 Global Head of Healthcare 54
7.8 About GlobalData 55
7.9 Disclaimer 55